H(ome)bA1c testing and telemedicine: High satisfaction of people with diabetes for diabetes management during COVID-19 lockdown

Kanc, Karin; Komel, Jana; Kos, Miha; Wagner, Julie

doi:10.1016/j.diabres.2020.108285

Cited by 20 publications

(25 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…(2020) USA Descriptive cross-sectional Prenatal visit March 17-May 31, 2020 283 out of 421 pregnant women who participated in at least one visit agreed to participate (65% response rate); 89% females; 84% Whites; 66.8% with college degrees Texas Telephone survey LOE VI Holtz (2020) USA Descriptive cross-sectional Not identified March 31-April 20, 2020 1011 participated the survey but data from 434 participants who had used telemedicine were included in their analysis; 89% females Survey LOE VI Itamura et al. (2020) USA Descriptive Otolaryngo-logy clinic January 1-May 1, 20,202 195 virtual visits and 4013 in-person visits California Survey LOE VI Kanc et al. (2020) Slovenia Descriptive Pilot study DM April – May 2020 98, 60% women, with mean age of 52 (SD=15.1), recent A1C level 7.1% Telephone Survey LOE VI Layfield et al.…”

Section: Resultsmentioning

confidence: 99%

“… ITAMURA ET AL. (2020) Providers have used Doximity Dialer videoconferencing software for most visits, with FaceTime as an alternative KANC ET AL. (2020) Patients chose telephone (90%), WhatsApp (6%) and Skype (2%) to discuss results LAYFIELD ET AL.…”

Section: Resultsmentioning

confidence: 99%

“…(2020) reported that patients were more satisfied with inpatient (93%) rather than virtual consultation (93% vs. 74%, respectively). One study did not report any score on patient satisfaction but reported high level based on caregiver's positive comments with use of telehealth ( Kanc et al., 2020 ).…”

Section: Resultsmentioning

confidence: 99%

“…[lower score represents higher satisfaction] itamura et al. (2020) inpatient visit satisfaction survey – 93% virtual visit satisfaction survey – 74% Kanc et al. (2020) Almost all had positive comments about telemedicine appointment and 72% would consider after Covid-19 Layfield et al.…”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Satisfaction with the use of telehealth during COVID-19: An integrative review

Andrews

Berghofer

Long

et al. 2020

International Journal of Nursing Studies Advances

191

141

View full text Add to dashboard Cite

Background The novel coronavirus (COVID-19) pandemic has defined 2020 thus far. Businesses, social and religious gatherings, travel, and almost all forms of transportation shut down to halt the spread of COVID-19. People were ordered to quarantine in place, and the world appears to go into a standstill. In the midst of being quarantined people with acute and chronic conditions still require medical care and treatment. An alternative way for people to receive needed health care was necessary. Hence, we saw an unprecedented surge in telehealth. With this unprecedented surge in use of telehealth, there is matter of delivering quality care. Objective Guided by the Donabedian Model, the purpose of this integrative review was to examine current evidence on patient and healthcare provider's satisfaction with the use of telehealth during the COVID-19 pandemic. Design An integrative review of the literature Data sources The literature review was conducted utilizing PubMED, CINAHL, Google Scholar and Cochrane Library databases. Inclusion criteria were studies published from January 2020 to July 11, 2020, published and translated in English language, and studies that evaluated patients and providers satisfaction with the use of telehealth or telemedicine during COVID-19. Eighteen articles were included in this review. Review methods An evaluation matrix was developed to collect data from the included articles. The articles were appraised using Fineout-Overholt & Gallagher-Ford Rapid Critical Appraisal Checklist for Descriptive Studies and Rapid Critical Appraisal of Evidence-Based Practice Implementation or Quality Improvement Projects (Melnyk & Fineout-Overholt, 2015). Authors independently appraised each article using the appropriate appraisal tools. Results Ten of the articles (53%) included were studies conducted in the United States. Sixteen out of 18 studies evaluated patient satisfaction and five studies examined healthcare providers’ satisfaction with the use of telehealth. The majority of telehealth services offered were by subspecialists. Overall, patients and healthcare providers have high level of satisfaction with the use of telehealth during COVID-19 pandemic. Many patients and healthcare providers reported willingness to continue using telehealth after the pandemic. Conclusion This integrative review provided additional evidence on patient and healthcare provider's satisfaction with the use of telehealth. Findings in this review may not be surprising as individuals, healthcare providers, and health systems needed to adopt the use telehealth due to necessity. However, the results for telehealth are promising.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Satisfaction with the use of telehealth during COVID-19: An integrative review

Andrews

Berghofer

Long

et al. 2020

International Journal of Nursing Studies Advances

191

141

View full text Add to dashboard Cite

show abstract

“…As a matter of fact, they should receive medical assistance to adjust their therapy during the pandemic and be oriented to adapt healthy habits and behaviors [ 15 ]. Telemedicine, in its different forms, from teleconsultation to telediagnosis, should be considered [ 7 , 14 , 15 , [31] , [32] , [33] , [35] , [36] , [37] ], as well as mobile options for collecting samples at the individuals’ homes or using point-of-care equipment and, this way, avoid putting them at risk leaving their homes for in-person consultations or exams [ 18 , 38 , 39 ].…”

Section: Discussionmentioning

confidence: 99%

Decentralized COVID-19 measures in Brazil were ineffective to protect people with diabetes

Barone

Harnik

Chaluppe³

et al. 2020

Diabetes & Metabolic Syndrome: Clinical Research & Revi

View full text Add to dashboard Cite

Background and aims COVID-19 severity and mortality are elevated in individuals with diabetes. During the pandemic, interventions recommended globally for people with diabetes were to keep blood glucose on target whilst staying at home to curb the spread of the virus. In Brazil, similar measures were proposed. The aim of our observational study was to assess whether these measures achieved their objectives. Methods : An anonymous and untraceable survey was shared from April 22nd to May 4th. States with more than 30 respondents were included in the analysis and Fisher's exact test was performed to identify associations, with p < 0.05 considered significant. Results: Type 1 diabetes and female participants were prevalent, 60.76% and 76.12% respectively. 10 out of 26 states were included, in addition to the federal district (1562 responses). Only in three states (Bahia, Goiás and Pernambuco) less than 50% of the respondents experienced higher glycemia or higher variability during the pandemic. Goiás state, where almost half of the respondents (49.12%) have private insurance, presented the highest percentage of individuals receiving medicines for three months (35.48%) and one of the lowest percentages of blood glucose deterioration (47.17%). In the large states of Minas Gerais, Rio de Janeiro and São Paulo, consultations and/or lab exams were postponed by 37.14%, 34.33% and 40.88%, respectively. Conclusions: The decentralized measures implemented by states in Brazil left most people with diabetes unprotected. Many were forced to venture outside to collect or to purchase their monthly medical supplies and reported increased glycemic levels and/or variability.

show abstract

The Impact of COVID-19 Lockdown on Metabolic Control and Access to Healthcare in People with Diabetes: the CONFI-DIAB Cross-Sectional Study

et al. 2021

View full text Add to dashboard Cite

Introduction:The COVID-19 pandemic led to an international health crisis and restrictions. While the phenotype associated with COVID-19 severity in people with diabetes has rapidly been explored, the impact of restrictive measures, including lockdown, and tertiary care disruption on metabolic control and access to healthcare remained unknown. The aim of our study was to provide a comprehensive assessment on the overall management of diabetes during lockdown, including glucose control, weight changes, health care consumption and use of alternative forms of care such as telemedicine services, in a large sample of patients with type 1 (T1DM) or type 2 diabetes mellitus (T2DM). Methods: A prioritization of a care self-administered questionnaire was sent at the end of the first COVID-19 lockdown to all patients with diabetes routinely followed by diabetologists from the University Hospital of Nancy (France).

show abstract

H(ome)bA1c testing and telemedicine: High satisfaction of people with diabetes for diabetes management during COVID-19 lockdown

Cited by 20 publications

References 3 publications

Satisfaction with the use of telehealth during COVID-19: An integrative review

Satisfaction with the use of telehealth during COVID-19: An integrative review

Decentralized COVID-19 measures in Brazil were ineffective to protect people with diabetes

The Impact of COVID-19 Lockdown on Metabolic Control and Access to Healthcare in People with Diabetes: the CONFI-DIAB Cross-Sectional Study

Contact Info

Product

Resources

About